Phase II trial of tepotinib vs sorafenib for treatment-naïve advanced hepatocellular carcinoma (HCC) in Asian patients

Authors :: C.-J. Yen
Hongming Pan
C. Zhao
D. Zhou
B.-H. Kim
Kun-Ming Rau
Zhenggang Ren
Hoseung Choi
Joong-Won Park
J. Straub
Tae Yong Kim
Baek-Yeol Ryoo
Shukui Qin
Jihyeung Kim
Source :: Annals of Oncology. 29:ix58-ix59
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
Sorafenib
Therapy naive
medicine.medical_specialty
business.industry
Hepatocellular carcinoma
Internal medicine
medicine
Hematology
medicine.disease
business
medicine.drug

Tools